Chen Junfeng, Zhang Shaoquan, Cao Xian, Daer Dili, Lin Bingliang
Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510000, China.
Medical Affairs, Takeda (China) Holdings Co., Ltd, Shanghai, 200126, China.
Adv Ther. 2025 Jun;42(6):2639-2658. doi: 10.1007/s12325-024-03086-3. Epub 2025 Apr 18.
Digital therapeutics have developed rapidly in recent years, providing a new method for disease management. The burden of liver diseases in China is heavy, and there are obvious problems in disease management. This paper expounds on the definition and classification of digital therapeutics, introduces their application in liver disease treatment and management in detail, and analyzes their development prospects in the field of liver diseases and future challenges.Graphical abstract available for this article.
近年来,数字疗法发展迅速,为疾病管理提供了一种新方法。中国肝脏疾病负担沉重,疾病管理存在明显问题。本文阐述了数字疗法的定义和分类,详细介绍了其在肝脏疾病治疗和管理中的应用,并分析了其在肝脏疾病领域的发展前景及未来挑战。本文提供图形摘要。